Mechanisms of Endogenous DNA Damage Promotion
Mechanisms of Endogenous DNA Damage Promotion
批准号:
10206079
负责人:
Kyle M Miller
金额:
$66.22万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-07-01 至 2025-06-30
关键词:
Alzheimer&aposs DiseaseAutomobile DrivingBacterial DNABiological MarkersBiological ProcessCancer DiagnosticsCancer EtiologyCancer ModelCellsClosure by clampDNADNA BindingDNA DamageDNA MethylationDNA Modification MethylasesDNA RepairDNA Repair GeneDNA Sequence AlterationDNA StructureDNA replication forkDataDefectDiagnosisDiagnosticDiseaseDisease susceptibilityDrug TargetingEquilibriumEscherichia coliEventGene ProteinsGenesGenomeGenomic InstabilityGoalsHeat shock proteinsHumanHuman CloningLinkMalignant NeoplasmsMapsMethylationMismatch RepairModelingMolecularMutagenesisMutationOncogenesOncogenicOncoproteinsOutputOxidesPathologyPatient-Focused OutcomesPharmaceutical PreparationsPhenotypeProteinsRNAReagentRoleRouteSamplingSignal TransductionSingle-Stranded DNATestingTherapeuticTranslationsWorkanti-cancerbasecancer biomarkerscancer preventioncostexperimental studygain of functiongenome sequencinggenome-widehuman DNAhuman DNA damagehuman modelinhibitor/antagonistinnovationinsightloss of functionloss of function mutationnovel anticancer drugpredictive modelingprotein functionrelating to nervous systemscreeningsuccesssynthetic constructtranscription factortranscriptometranslation to humanstumorwhole genome
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Mechanisms of Endogenous DNA Damage Promotion
Identification of the oncogenic mechanisms underlying cancer-promoting mutations remains a critical bottleneck
in translation of discovered cancer-gene identities into effective anti-cancer strategies. Furthermore, strong
correlations of Alzheimer’s disease (AD) with cancers indicate that these mechanisms also underlie AD. Their
identification may allow fundamentally new AD pre-disease biomarkers, diagnostic, preventative and possibly
therapeutic strategies. The goal of this multi-PI project is to leverage the team’s discovery in Escherichia coli,
and its immediate translation to human homologs, of large, diverse, conserved networks of proteins that promote
endogenous DNA damage and genome instability when overproduced—the DNA “Damage-up” Proteins (DDPs).
DDP identities and mechanisms discovered indicate that many known and unknown overproduced oncoproteins
are likely to constitute oncogenic and AD-associated mechanisms in which pathologies arise from destabilization
of genomes rather than via the proteins’ other specific cell-biological functions. A network of E. coli DDPs
promote endogenous DNA damage and mutation when overproduced, modeling many overproduction
oncoproteins. The human homologs are highly enriched among known cancer driving genes, and their RNAs in
cancers predict heavy tumor mutation loads and poor patient outcomes. 46% of human homologs sampled
promote DNA damage and mutagenesis when overproduced in human cells, demonstrating the power of the E.
coli platform for predicting human functions. Unlike genome instability and cancer caused by DNA-repair gene
loss-of-function mutations, DDPs promote genome instability as gain-of-function alterations (overproduction),
and so potentially can be drugged. DDPs defy previous cancer-gene/protein functional classes because they
destabilize genomes but are not DNA-repair genes that suppress mutation rate, but instead are instigators of
endogenous DNA damage and genome instability via mechanisms previously poorly defined. This project is
aimed at revealing fundamental conserved mechanisms and consequences of endogenous DNA-damage
promotion by DDPs using the E. coli model to guide cancer-protein function discovery in human cells. Because
the DDPs and their activites are a new and innovative conceptual paradigm, we expect results of this project to
re-direct many ongoing efforts in cancer prevention, diagnosis, and treatment. Because vast numbers and kinds
of proteins are implicated, and cancer is strongly correlated with AD, increased endogenous DNA damage may
be a widespread biomarker for cancer and AD susceptibility.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of Endogenous DNA Damage Promotion
-
批准号:10458508
-
项目类别:
-
资助金额:$64.89万
-
财政年份:2020
-
负责人:Kyle M Miller
-
依托单位:
Mechanisms of Endogenous DNA Damage Promotion
-
批准号:10013865
-
项目类别:
-
资助金额:$67.67万
-
财政年份:2020
-
负责人:Kyle M Miller
-
依托单位:
Mechanisms of Endogenous DNA Damage Promotion
-
批准号:10658879
-
项目类别:
-
资助金额:$64.89万
-
财政年份:2020
-
负责人:Kyle M Miller
-
依托单位:
Shaping DNA Damage Response Networks Via Histone H2A Variants
-
批准号:9254533
-
项目类别:
-
资助金额:$38.53万
-
财政年份:2016
-
负责人:Kyle M Miller
-
依托单位:
Shaping DNA Damage Response Networks Via Histone H2a Variants
-
批准号:10608423
-
项目类别:
-
资助金额:$38.62万
-
财政年份:2016
-
负责人:Kyle M Miller
-
依托单位:
MECHANISMS OF GENOME MAINTENANCE BY BROMODOMAIN CHROMATIN READER PROTEINS
-
批准号:9294006
-
项目类别:
-
资助金额:$35.28万
-
财政年份:2016
-
负责人:Kyle M Miller
-
依托单位:
Shaping DNA Damage Response Networks Via Histone H2A Variants
-
批准号:9892977
-
项目类别:
-
资助金额:$35.28万
-
财政年份:2016
-
负责人:Kyle M Miller
-
依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
-
批准号:81000622
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:梁胜
-
依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
-
批准号:31060293
-
项目类别:地区科学基金项目
-
资助金额:26.0万元
-
批准年份:2010
-
负责人:郭亚芬
-
依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
-
批准号:30960334
-
项目类别:地区科学基金项目
-
资助金额:22.0万元
-
批准年份:2009
-
负责人:董贵成
-
依托单位: